Table 2.

Primary data of the patients included in the study

Patientcharacteristics		Number/total patients	Percentage
Sex	Male	13/27	48
Female	14/27	52
MRD	MRD+	8/27	29.63
MRD-	11/27	40.74
Relapse	in Bone marrow	8/27	29.63
WBC	>50,000/µL whole blood	10/27	37

Note: MRD, minimal residual disease determined in new case patients one year after treatment.

Abbreviations: MRD, minimal residual disease; WBC, white blood cell.